Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors. (15th February 2015) - Armenia, D.; Carioti, L.; Di Maio, V.C.; Bellocchi, M.C.; Di Paolo, D.; Guerrieri, F.; Calvo, L.; Cento, V.; Tontodonati, M.; Micheli, V.; De Leonardis, F.; Aragri, M.; et al.